India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 949.99 billion. The enterprise value is 1.00 trillion.
| Market Cap | 949.99B |
| Enterprise Value | 1.00T |
Important Dates
The last earnings date was Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
NSE:ZYDUSLIFE has 1.01 billion shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 1.01B |
| Shares Outstanding | 1.01B |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 75.09% |
| Owned by Institutions (%) | 13.56% |
| Float | 248.90M |
Valuation Ratios
The trailing PE ratio is 19.31 and the forward PE ratio is 21.81. NSE:ZYDUSLIFE's PEG ratio is 1.49.
| PE Ratio | 19.31 |
| Forward PE | 21.81 |
| PS Ratio | 3.88 |
| PB Ratio | 3.38 |
| P/TBV Ratio | 10.17 |
| P/FCF Ratio | 37.43 |
| P/OCF Ratio | 22.92 |
| PEG Ratio | 1.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.31, with an EV/FCF ratio of 39.54.
| EV / Earnings | 20.40 |
| EV / Sales | 4.10 |
| EV / EBITDA | 14.31 |
| EV / EBIT | 16.63 |
| EV / FCF | 39.54 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.94 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 3.80 |
| Interest Coverage | 26.90 |
Financial Efficiency
Return on equity (ROE) is 19.25% and return on invested capital (ROIC) is 12.04%.
| Return on Equity (ROE) | 19.25% |
| Return on Assets (ROA) | 9.54% |
| Return on Invested Capital (ROIC) | 12.04% |
| Return on Capital Employed (ROCE) | 15.96% |
| Revenue Per Employee | 8.77M |
| Profits Per Employee | 1.76M |
| Employee Count | 27,917 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, NSE:ZYDUSLIFE has paid 14.91 billion in taxes.
| Income Tax | 14.91B |
| Effective Tax Rate | 22.86% |
Stock Price Statistics
The stock price has decreased by -5.03% in the last 52 weeks. The beta is 0.42, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -5.03% |
| 50-Day Moving Average | 1,002.10 |
| 200-Day Moving Average | 950.24 |
| Relative Strength Index (RSI) | 33.87 |
| Average Volume (20 Days) | 868,737 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 244.94 billion and earned 49.20 billion in profits. Earnings per share was 48.89.
| Revenue | 244.94B |
| Gross Profit | 175.33B |
| Operating Income | 59.77B |
| Pretax Income | 65.21B |
| Net Income | 49.20B |
| EBITDA | 69.38B |
| EBIT | 59.77B |
| Earnings Per Share (EPS) | 48.89 |
Balance Sheet
The company has 70.69 billion in cash and 96.36 billion in debt, giving a net cash position of -25.68 billion or -25.52 per share.
| Cash & Cash Equivalents | 70.69B |
| Total Debt | 96.36B |
| Net Cash | -25.68B |
| Net Cash Per Share | -25.52 |
| Equity (Book Value) | 280.90B |
| Book Value Per Share | 251.49 |
| Working Capital | 88.65B |
Cash Flow
In the last 12 months, operating cash flow was 41.44 billion and capital expenditures -16.06 billion, giving a free cash flow of 25.38 billion.
| Operating Cash Flow | 41.44B |
| Capital Expenditures | -16.06B |
| Free Cash Flow | 25.38B |
| FCF Per Share | 25.22 |
Margins
Gross margin is 71.58%, with operating and profit margins of 24.40% and 20.09%.
| Gross Margin | 71.58% |
| Operating Margin | 24.40% |
| Pretax Margin | 26.62% |
| Profit Margin | 20.09% |
| EBITDA Margin | 28.33% |
| EBIT Margin | 24.40% |
| FCF Margin | 10.36% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | 266.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.47% |
| Buyback Yield | 0.27% |
| Shareholder Yield | 1.44% |
| Earnings Yield | 5.18% |
| FCF Yield | 2.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |